Results 351 to 360 of about 151,098 (403)
Some of the next articles are maybe not open access.

Related searches:

Neurotoxicity of midazolam in the rabbit

Pain, 1999
Safe and efficient use of spinal drugs requires neurotoxicologic animal studies before ethical application. We have evaluated the neurotoxicologic interruptions of intrathecal administration of midazolam in rabbits. Eighteen white New Zealand rabbits were randomly assigned into three groups consisting of six rabbits each. In conscious animals, 0.3 ml 0.
Nejat Savci   +7 more
openaire   +3 more sources

Midazolam and flumazenil in gastroenterologys

Acta Anaesthesiologica Scandinavica, 1990
Flumazenil, a specific benzodiazepine antagonist, has been used to reverse sedation in a double‐blind, controlled study of patients undergoing upper gastrointestinal (GI) endoscopy. Forty patients in each of two centres were given a standard dose of either flumazenil (n = 40) or placebo (n = 40) after gastroscopy under midazolam sedation.
K. D. Bardhan   +3 more
openaire   +2 more sources

The Chronic Efficacy of Midazolam

International Clinical Psychopharmacology, 1990
The chronic efficacy of midazolam 15.0 mg was studied in 2 male and 10 female subjects. Only subjects with a complaint of sleep latency insomnia which was verified by polysomnography were included in the study. Following a screening and adaptation period, subjects spent 3 consecutive nights in the laboratory during the weeks of the study.
James Lamphere   +5 more
openaire   +3 more sources

Midazolam and flumazenil in neuroanaesthesia

Acta Anaesthesiologica Scandinavica, 1990
Of the numerous benzodiazepines currently available, only a few are used in anaesthetic practice. Midazolam is utilised as a premedicant, sedative, and an induction agent and produces minimal depression of ventilation or of the cardiovascular system. The anticonvulsant activity is similar to that of diazepam.
Eberhard Kochs, J. Schulte am Esch
openaire   +3 more sources

Flumazenil and midazolam in anaesthesia

Acta Anaesthesiologica Scandinavica, 1995
Flumazenil, the first benzodiazepine antagonist, is currently used widely as an emergency drug, and has also been utilized in planned procedures, to time arousal intra‐ or post‐operatively. It is known that flumazenil, used at the end of a procedure, causes instant recovery by reversing the residual effects of, for example, midazolam.
openaire   +2 more sources

The use of midazolam in premedication

Acta Anaesthesiologica Scandinavica, 1990
Socio‐psychological factors, such as increased anxiety in developed societies and cultures, and separation anxiety, particularly in children, justify the use of premedicants. In addition, the link between a central nervous “anxiety centre” and biochemical stress responses is blocked by an efficient anxiolytic.
openaire   +3 more sources

Pharmacokinetics of midazolam in the aged

European Journal of Clinical Pharmacology, 1984
The pharmacokinetics of midazolam, an imidazo-benzodiazepine derivative, have been studied in 13 subjects over the age of 60 years who received the drug intravenously (0.07 mg kg-1) as an induction agent for endoscopy. Two to three days later, 6 of these subjects received 5 mg of midazolam intramuscularly, and another 6 of the subjects received 10 mg ...
Smith M.T.   +4 more
openaire   +4 more sources

The pharmacokinetics of midazolam in man

European Journal of Clinical Pharmacology, 1981
Midazolam, a new water-soluble benzodiazepine, was administered as: i) 5 mg intravenously, ii) a 10-mg oral solution and iii) a 10-mg oral tablet, to six volunteers whose informed consent had been obtained. Midazolam plasma concentrations were measured using an electron-capture gas-liquid chromatographic assay.
Smith, MT, Eadie, MJ, Brophy, TO
openaire   +3 more sources

Home - About - Disclaimer - Privacy